Researchers have designed a new model of life expectancy that's based less on disease diagnosis, and more on other factors including cholesterol levels and lifestyle.
The sex of the drinker in addition to the brewing method may explain coffee's link to increased cholesterol. Drinking 3-5 cups of espresso per day increased serum total cholesterol, especially in males.
Mouse study reveals how depression and chronic stress can have an impact on cholesterol-lowering medications and influence the risk of heart disease.
Low HDL and high triglyceride levels in the blood at 35 were associated with an increased risk of developing Alzheimer's disease later in life. Additionally, higher glucose levels between 51 and 60 were linked to a higher risk of Alzheimer's.
Study reports oligodendrocytes in the brain are distinct from oligodendrocytes in the central nervous system due to their metabolic processes. The findings may shed new light on neurological and autoimmune dysfunction in multiple sclerosis and other neurodegenerative disorders.
Cyclodextrin, an FDA-approved drug, reduced cholesterol accumulation from broken down brain cells and inflammation in animal models. The findings point to a potential new therapy to reduce dementia following a stroke.
Researchers found those on the autism spectrum with low high-density lipoprotein cholesterol or decreased ApoA1 levels had lower adaptive functioning than others with ASD.
Cholesterol synthesis in nerve cells ensures the replenishment of newly myelin-forming cells. The findings could provide new treatment options for the treatment of disorders associated with myelin loss, such as multiple sclerosis.
Stem cell study reveals astrocytes carrying the Alzheimer's associated APOE4 gene release more cholesterol than those carrying the APOE3 gene. Findings shed light on how different versions of the APOE gene in astrocytes influence amyloid-beta production and how the oversupply of cholesterol associated with APOE4 astrocytes may promote amyloid-beta formation in Alzheimer's patients.
Cholesterol produced by astrocytes in the brain is required for the production of amyloid-beta. The findings shed light on how and why amyloid-beta forms, and may explain why genes associated with cholesterol have been implicated as risk factors for Alzheimer's disease.
A study conducted on Japanese men and women found peanut consumption decreased the risk of cardiovascular disease and ischemic stroke.
Lower cholesterol levels may put people with schizophrenia at higher risk for violent behaviors, including self-harm and suicide. Researchers say lower cholesterol levels make brain cells less sensitive to serotonin, increasing symptoms of depression, impulsivity, and aggression.